Methicillin-resistant Staphylococcus aureus in hospitals and the community: stealth dynamics and control catastrophes

Proceedings of the National Academy of Sciences of the United States of America
B S CooperS Ebrahim

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) represents a serious threat to the health of hospitalized patients. Attempts to reduce the spread of MRSA have largely depended on hospital hygiene and patient isolation. These measures have met with mixed success: although some countries have almost eliminated MRSA or remained largely free of the organism, others have seen substantial increases despite rigorous control policies. We use a mathematical model to show how these increases can be explained by considering both hospital and community reservoirs of MRSA colonization. We show how the timing of the intervention, the level of resource provision, and chance combine to determine whether control measures succeed or fail. We find that even control measures able to repeatedly prevent sustained outbreaks in the short-term can result in long-term control failure resulting from gradual increases in the community reservoir. If resources do not scale with MRSA prevalence, isolation policies can fail "catastrophically."

References

Feb 1, 1991·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·V T Rosdahl, A M Knudsen
Aug 1, 1996·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·C M Vandenbroucke-Grauls
Jan 20, 1999·QJM : Monthly Journal of the Association of Physicians·M FarringtonN M Brown
Jun 9, 1999·Proceedings of the National Academy of Sciences of the United States of America·D J AustinR M Anderson
Mar 4, 2000·Proceedings of the National Academy of Sciences of the United States of America·M LipsitchB R Levin
Jun 29, 2000·American Journal of Epidemiology·G De SerresC P Farrington
Feb 15, 2001·The Journal of Hospital Infection·F FitzpatrickL E Fenelon
Apr 24, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A ScanvicJ C Lucet
Jul 27, 2001·Epidemiology and Infection·L AbuduK K Cheng
Apr 12, 2002·Proceedings of the National Academy of Sciences of the United States of America·Inti PelupessyOdo Diekmann
Apr 12, 2002·The Lancet Infectious Diseases·Duarte C OliveiraHermínia de Lencastre
Dec 21, 2002·The Journal of Antimicrobial Chemotherapy·Peter WilsonM Robbins
Jan 11, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Cassandra D SalgadoDavid P Calfee
Feb 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·David L SmithSimon A Levin
Apr 1, 2004·Biostatistics·Ben Cooper, Marc Lipsitch

❮ Previous
Next ❯

Citations

Feb 14, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·H Humphreys
Jan 24, 2006·Journal of Industrial Microbiology & Biotechnology·Punyasloke BhaduryPhillip C Wright
Apr 29, 2011·Epidemiology and Infection·A ManzurUNKNOWN Spanish Network for Research in Infectious Diseases
Sep 12, 2012·Epidemiology and Infection·P GrohsG Meyer
Mar 5, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Danya LiuJacek Hawiger
Mar 21, 2012·Proceedings of the National Academy of Sciences of the United States of America·Weixiong KeMarc Lipsitch
Feb 16, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stan Deresinski
Jun 29, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Emilian Armeanu, Marc J M Bonten
Jul 19, 2008·American Journal of Epidemiology·Ben S CooperGeoffrey M Scott
May 11, 2013·American Journal of Epidemiology·Ian H SpicknallJoseph N S Eisenberg
Apr 12, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Tanya GurievaMarc J M Bonten
Jul 5, 2012·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Timothy Graham Lawes, Ian M Gould
Jan 18, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Martin C J Bootsma, Marc J M Bonten
Oct 10, 2008·The Journal of Antimicrobial Chemotherapy·Russell HopeUNKNOWN BSAC Working Parties on Resistance Surveillance
Nov 26, 2010·The Journal of Antimicrobial Chemotherapy·Martin WolkewitzUNKNOWN BURDEN Study Group
Jul 2, 2011·The Journal of Antimicrobial Chemotherapy·Heidi S M AmmerlaanUNKNOWN MRSA Eradication Study Group
Sep 29, 2011·The Journal of Antimicrobial Chemotherapy·David WyllieDerrick Crook
Apr 24, 2012·The Journal of Antimicrobial Chemotherapy·David J HetemMartin C J Bootsma
Jan 13, 2005·Critical Care Medicine·John R HotchkissPhilip S Crooke
Apr 7, 2011·Current Opinion in Infectious Diseases·Lulla OpatowskiLaura Temime
Sep 24, 2010·Journal of the Royal Society, Interface·Martin C J BootsmaMarc J M Bonten
May 11, 2012·Journal of the Royal Society, Interface·Ian M HallStéphane Hugonnet
May 13, 2011·Science Translational Medicine·Graham F Medley
Oct 29, 2005·BMJ : British Medical Journal·Georgia Duckworth, Andr Charlett
Aug 5, 2006·BMJ : British Medical Journal·John Paul
Jul 3, 2013·BMC Infectious Diseases·Esther van KleefWilliam J Edmunds
Mar 28, 2006·Critical Care : the Official Journal of the Critical Care Forum·Marc J Struelens, Olivier Denis
Jun 30, 2005·PLoS Medicine·David L SmithJ Glenn Morris

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
M C J BootsmaM J M Bonten
Proceedings of the National Academy of Sciences of the United States of America
David L SmithSimon A Levin
The Lancet Infectious Diseases
Hajo Grundmann, B Hellriegel
Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America
Marie Forrester, A N Pettitt
© 2022 Meta ULC. All rights reserved